- Home
- DSP vs MXCT Comparison
DSP vs MXCT Comparison
Compare DSP & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSP
- MXCT
- Stock Information
- Founded
- DSP 1999
- MXCT 1999
- Country
- DSP United States
- MXCT United States
- Employees
- DSP N/A
- MXCT N/A
- Industry
- DSP EDP Services
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DSP Technology
- MXCT Health Care
- Exchange
- DSP Nasdaq
- MXCT Nasdaq
- Market Cap
- DSP 220.3M
- MXCT 239.2M
- IPO Year
- DSP 2021
- MXCT 2021
- Fundamental
- Price
- DSP $12.70
- MXCT $2.06
- Analyst Decision
- DSP Strong Buy
- MXCT Strong Buy
- Analyst Count
- DSP 8
- MXCT 1
- Target Price
- DSP $21.75
- MXCT $9.00
- AVG Volume (30 Days)
- DSP 231.1K
- MXCT 922.0K
- Earning Date
- DSP 08-11-2025
- MXCT 08-05-2025
- Dividend Yield
- DSP N/A
- MXCT N/A
- EPS Growth
- DSP N/A
- MXCT N/A
- EPS
- DSP 0.13
- MXCT N/A
- Revenue
- DSP $306,484,000.00
- MXCT $37,675,000.00
- Revenue This Year
- DSP $18.36
- MXCT $8.82
- Revenue Next Year
- DSP $15.95
- MXCT $21.12
- P/E Ratio
- DSP $97.95
- MXCT N/A
- Revenue Growth
- DSP 30.64
- MXCT N/A
- 52 Week Low
- DSP $8.70
- MXCT $2.03
- 52 Week High
- DSP $26.33
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- DSP 40.59
- MXCT 39.29
- Support Level
- DSP $12.32
- MXCT $2.19
- Resistance Level
- DSP $13.26
- MXCT $2.28
- Average True Range (ATR)
- DSP 0.63
- MXCT 0.12
- MACD
- DSP -0.11
- MXCT 0.00
- Stochastic Oscillator
- DSP 16.14
- MXCT 7.81
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.